Robert Torray - Torray Investment Partners
Holding/activity history for Rocket Pharmaceuticals Inc. (RCKT)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | 0 | 0.00 | Sell 100.00% | 0.12 | SEC | ||
| 2025 Q1 | 117,301 | 0.12 | Reduce 3.93% | <0.01 | $6.67 | $782,398 | SEC |
| 2024 Q4 | 122,095 | 0.22 | Add 66.29% | 0.09 | $12.57 | $1,534,734 | SEC |
| 2024 Q3 | 73,424 | 0.19 | Add 9.24% | 0.02 | $18.47 | $1,356,141 | SEC |
| 2024 Q2 | 67,216 | 0.22 | Add 10.31% | 0.02 | $21.53 | $1,447,160 | SEC |
| 2024 Q1 | 60,933 | 0.25 | Add 0.13% | <0.01 | $26.94 | $1,641,535 | SEC |
| 2023 Q4 | 60,856 | 0.30 | Add 1.13% | <0.01 | $29.97 | $1,823,854 | SEC |
| 2023 Q3 | 60,177 | 0.22 | Add 10.28% | 0.02 | $20.49 | $1,233,027 | SEC |
| 2023 Q2 | 54,569 | 0.19 | Add 0.62% | <0.01 | $19.87 | $1,084,286 | SEC |
| 2023 Q1 | 54,232 | 0.17 | Reduce 0.17% | <0.01 | $17.13 | $928,994 | SEC |
| 2022 Q4 | 54,324 | 0.19 | Reduce 4.61% | <0.01 | $19.57 | $1,063,121 | SEC |
| 2022 Q3 | 56,951 | 0.18 | Reduce 5.83% | <0.01 | $15.96 | $909,000 | SEC |
| 2022 Q2 | 60,475 | 0.16 | Add 38.53% | 0.04 | $13.76 | $832,000 | SEC |
| 2022 Q1 | 43,655 | 0.11 | Add 19.77% | 0.02 | $15.85 | $692,000 | SEC |
| 2021 Q4 | 36,449 | 0.12 | Reduce 3.53% | <0.01 | $21.84 | $796,000 | SEC |
| 2021 Q3 | 37,782 | 0.17 | Add 1.13% | <0.01 | $29.88 | $1,129,000 | SEC |
| 2021 Q2 | 37,360 | 0.24 | Add 28.56% | 0.05 | $44.30 | $1,655,000 | SEC |
| 2021 Q1 | 29,061 | 0.20 | Reduce 15.68% | 0.05 | $44.35 | $1,289,000 | SEC |
| 2020 Q4 | 34,464 | 0.31 | Reduce 29.37% | 0.06 | $54.84 | $1,890,000 | SEC |
| 2020 Q3 | 48,795 | 0.20 | Add 0.45% | <0.01 | $22.85 | $1,115,000 | SEC |
| 2020 Q2 | 48,577 | 0.19 | Reduce 13.96% | 0.02 | $20.94 | $1,017,000 | SEC |
| 2020 Q1 | 56,458 | 0.17 | Add 87.83% | 0.08 | $13.96 | $788,000 | SEC |
| 2019 Q4 | 30,058 | 0.12 | Buy | 0.12 | $22.76 | $684,000 | SEC |